DOCS Jan 2024 27.500 put

OPR - OPR Delayed price. Currency in USD
3.0000
+0.0500 (+1.69%)
As of 03:30PM EDT. Market open.
Stock chart is not supported by your current browser
Previous close2.9500
Open3.0000
Bid2.8500
Ask3.2000
Strike27.50
Expiry date2024-01-19
Day's range3.0000 - 3.0000
Contract rangeN/A
Volume4
Open interest368
  • Motley Fool

    1 No-Brainer Stock to Buy With $100 Right Now

    After doubling on its first day of trading and nearly doubling again in the next few months, shares of Doximity (NYSE: DOCS) have been on a steady march downward -- losing over 70% of its value from its all-time highs. Doximity's stock was caught in the all-too-common trap of initial public offering (IPO) hype, followed by a year or more of turbulence as the business settled into being a public company. This divergence between share price and operational performance leaves us wondering: Is now the time to buy Doximity at roughly 35% above its all-time lows?

  • Zacks

    Doximity (DOCS) Reports Q4 Earnings: What Key Metrics Have to Say

    Although the revenue and EPS for Doximity (DOCS) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

  • Business Wire

    Doximity to Present at the William Blair 43rd Annual Growth Stock Conference

    SAN FRANCISCO, May 23, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Dr. Nate Gross, co-founder and chief strategy officer, will present at the William Blair 43rd Annual Growth Stock Conference on Thursday, June 8, 2023 at 10:00 a.m. Central Time.

  • Motley Fool

    2 Growth Stocks Billionaires Keep Buying Hand Over Fist

    The next time you go looking for the best possible growth stocks to buy, remember that you don't have to reinvent the wheel every time. Every three months, the U.S. Securities and Exchange Commission (SEC) makes just about anyone with over $100 million under management report their trading activities and the latest round of quarterly disclosures. Billionaire Steven Cohen and the fund he manages, Point72, bought nearly 675,000 shares of Doximity (NYSE: DOCS) in the first quarter.

  • Motley Fool

    SaaS Stocks Aren't Out of the Woods Just Yet

    Mixed results from software platform providers show the jury's still out on the business model's viability.

  • Zacks

    Doximity (DOCS) Q4 Earnings and Revenues Top Estimates

    Doximity (DOCS) delivered earnings and revenue surprises of 17.65% and 0.78%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Doximity Announces New Integration with MEDITECH

    SAN FRANCISCO, May 16, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced an integration with MEDITECH, one of the most widely used electronic health record (EHR) systems in the United States. The integration enables medical professionals to launch a Doximity Dialer voice or video telehealth visit directly from MEDITECH’s physician-facing native app, Expanse Now.

  • Business Wire

    Doximity Announces Fourth Quarter and Fiscal Year 2023 Financial Results and New Senior Leadership Hires

    SAN FRANCISCO, May 16, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2023 fourth quarter and fiscal year ended March 31, 2023. The company also announced the appointment of two new senior leadership members, Craig Overpeck as SVP of commercial operations and Ben Greenberg as SVP of commercial products.

  • Zacks

    Nutex Health Inc. (NUTX) Reports Q1 Loss, Tops Revenue Estimates

    Nutex Health Inc. (NUTX) delivered earnings and revenue surprises of 50% and 1.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

  • Simply Wall St.

    Doximity, Inc. (NYSE:DOCS) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

    It is hard to get excited after looking at Doximity's (NYSE:DOCS) recent performance, when its stock has declined 3.8...

  • Zacks

    Charles River Laboratories (CRL) Q1 Earnings and Revenues Beat Estimates

    Charles River (CRL) delivered earnings and revenue surprises of 7.34% and 4.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

  • Motley Fool

    3 Best Stocks to Buy in May and Hold Forever

    In need of healthcare exposure in your portfolio? Consider holding these three promising companies forever.

  • Zacks

    Agilon Health (AGL) Surpasses Q1 Earnings and Revenue Estimates

    Agilon (AGL) delivered earnings and revenue surprises of 33.33% and 5.25%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Doximity to Release Fiscal 2023 Fourth Quarter Results on May 16, 2023

    SAN FRANCISCO, April 25, 2023--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter ended March 31, 2023 after market close on May 16, 2023. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.

  • Zacks

    ELV or DOCS: Which Is the Better Value Stock Right Now?

    ELV vs. DOCS: Which Stock Is the Better Value Option?

  • Business Wire

    Doximity Releases New Study on Physician Compensation and Impact of Overwork and Economic Pressures

    SAN FRANCISCO, March 23, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its annual Physician Compensation Report, revealing a slight decline of 2.4% in average pay for doctors in 2022. The report includes self-reported compensation data from over 190,000 U.S. doctors over six years and over 31,000 full-time physicians in the last year alone.

  • Business Wire

    Doximity to Host Inaugural Investor Day June 6, 2023

    SAN FRANCISCO, March 21, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it will host an Investor Day on Tuesday, June 6, 2023. The event will be held at the New York Stock Exchange in New York City from 10:30 a.m. to 1:30 p.m. Eastern Time.

  • Motley Fool

    Want $1 Million in Retirement? Invest $100,000 in These 3 Stocks and Wait 10 Years

    Patient investors who would like to see their investments rise 10x have some interesting options right now.

  • Motley Fool

    2 Top Growth Stocks to Buy Before the Next Bull Rally

    Runaway inflation has been a serious problem for the global economy for nearly two years now. Interest rates that have risen sharply to combat inflation have already begun destabilizing financial systems, and nobody's really sure where we'll go from here.

  • Motley Fool

    Could AI Supercharge This Growth Stock?

    Today, more than 80% of U.S. doctors already use Doximity. Could this new AI tool secure Doximity's leadership in the market -- and eventually supercharge the stock? Doximity generates revenue from pharmaceutical companies and hospital systems.

  • Motley Fool

    Want $1 Million in Retirement? Invest $200,000 in These 3 Stocks and Wait a Decade

    A basket balanced evenly across these three businesses could jump-start your journey to becoming a millionaire.

  • Motley Fool

    2 Beaten-Down Growth Stocks to Buy on the Dip

    For over a year now, growth stocks have been under a lot of pressure. For example, shares of Doximity (NYSE: DOCS) and SoFi Technologies (NASDAQ: SOFI) are down by more than half from their previous peaks. Shares of Doximity got way ahead of themselves when the all-digital bank made its stock market debut a few years ago.

  • Business Wire

    Doximity to Participate in the Raymond James 44th Annual Institutional Investors Conference

    SAN FRANCISCO, March 06, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will present at the Raymond James 44th Annual Institutional Investors Conference on Wednesday, March 8, 2023, at 9:15 a.m. Eastern Time/6:15 a.m Pacific Time.

  • Motley Fool

    Doximity Stock: Bear vs. Bull

    Doximity (NYSE: DOCS) has wowed investors with its solid list of customers, earnings growth, and top market position. After Doximity's June 2021 initial public offering, it climbed more than 90% in just a few months. Since, the stock performance hasn't reflected the company's successes.

  • Motley Fool

    Doximity Stock: Bull vs. Bear

    The online networking platform for medical professionals went on to lose roughly two-thirds of its market cap. Here are the bull and bear arguments for Doximity stock. Probably the best reason to buy Doximity stock now is that the company has a tremendous growth opportunity ahead.